FOLH1 and neoplasm: Kuo et al. reports 14.5 ± 1.83%IA/g tumor uptake at 4 h post injection for [177Lu]Lu-PSMA-617 while we saw 7.84 ± 0.46%IA/g tumor uptake at 5 h post injection for [165Er]Er-PSMA-617.